Pharma Journalist -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company

REGENXBIO and Nippon Shinyaku Form Exclusive Partnership to Develop RGX-121 and RGX-111 for MPS Diseases

Acadia Pharmaceuticals Submits EMA Application for Trofinetide in Rett Syndrome

FDA Accepts LEQEMBI BLA for Subcutaneous Dosing in Early Alzheimer’s Treatment

Daiichi Sankyo Acquires IP Rights for Anti-TA-MUC1 Antibody DS-3939 from Glycotope

Umoja Biopharma Secures $100M in Oversubscribed Series C to Advance CAR T Pipeline

Solid Biosciences Receives FDA IND Clearance for Dual Route Gene Therapy in Friedreich’s Ataxia